EUCTR2005-005698-31-HU进行中（未招募）不适用
Efficacy of fenofibrate treatment on the insulin sensitivity and pancreas ß-cell function in obese patients with hypertriglyceridemia.
ational Medical Center (Országos Gyógyintézeti Központ)0 个研究点目标入组 40 人开始时间: 2006年2月8日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Subjects with a diagnosis of meeting all criteria listed below will be included in the study:
- •· Age range 25 - 60 years,
- •· Gender: male and female,
- •· Hypertriglyceridemia > 1.7 mmol/L, but < 11 mmol/L,
- •· BMI from 30 to 40 kg/m2 and waist circumference of > 102 cm in male, and 88 cm in female,
- •· Patients with normal renal and liver function,
- •· Written informed consent obtained.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •· Subjects with abnormal results on blood lab tests of hepatic and renal function (ALT > 1.5 x ULN, creatinine > 130 µmol/L),
- •· History of previous or existing cardiovascular disease,
- •· Diabetes mellitus (type 1 or 2),
- •· Previously treated with fibrates,
- •· With known cholelithiasis in absence of cholecystectomy,
- •· Any kind of neoplasm or malignancies,
- •· Pharmacologically treated hyperlipidemia or oral anticoagulant treatment within 3 months before screening,
- •· Patient suspected with non-compliance,
- •· History of alcohol and/or any drug abuse.
研究者
相似试验
招募中
不适用
Effects of bezafibrate and fenofibrate on insulin sensitivity in patients with type 2 diabetes mellitus by the glucose clamp technique and the meal tolerance test.Type 2 diabetes mellitusJPRN-UMIN000012462Division of Cardiovascular Medicine, Endocrinology and Metabolism, Department of Molecular Medicine and Therapeutics, Tottori University Faculty of Medicine20
进行中（未招募）
不适用
Efficacy and Safety of FIAsp compared to insulin aspart both in Combination with insulin detemir in Adults with Type 1 DiabetesMedDRA version: 14.1Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 1EUCTR2010-024049-53-HUovo Nordisk A/S1,095
进行中（未招募）
不适用
Efficacy and Safety of FIAsp compared to insulin aspart both in Combination with insulin detemir in Adults with Type 1 DiabetesDiabetes Mellitus, Type 1MedDRA version: 16.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861EUCTR2010-024049-53-GBovo Nordisk A/S1,095
进行中（未招募）
不适用
Efficacy and Safety of FIAsp compared to insulin aspart both in Combination with insulin detemir in Adults with Type 1 DiabetesDiabetes Mellitus, Type 1EUCTR2010-024049-53-PLovo Nordisk A/S1,095
进行中（未招募）
不适用
Efficacy and Safety of FIAsp compared to insulin aspart both in Combination with insulin detemir in Adults with Type 1 DiabetesMedDRA version: 18.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 1EUCTR2010-024049-53-CZovo Nordisk A/S1,095